Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes. Redd RA, Ford J, Lei M, Abramson JS, et al. Leuk Lymphoma 2023;64:2296-2305.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Redd RA, Ford J, Lei M, Abramson JS, et al. Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes. Leuk Lymphoma 2023;64:2296-2305.
PMID: 37798861